Vtv Therapeutics Inc. (VTVT) SEC Filings — 2024
16 SEC filings for Vtv Therapeutics Inc. (VTVT) in 2024.
Filings
- vTv Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Vtv Therapeutics Inc. SC 13G Filing — SC 13G · Nov 12, 2024
- vTv Therapeutics Terminates Material Agreement — 8-K · Oct 25, 2024
- vTv Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- vTv Therapeutics Files 8-K — 8-K · Jul 26, 2024
- vTv Therapeutics Inc. Files 8-K for Material Definitive Agreement — 8-K · Jul 2, 2024
- vTv Therapeutics Files 8-K on Shareholder Matters — 8-K · Jun 14, 2024
- vTv Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- vTv Therapeutics Inc. Files Definitive Proxy Statement — DEF 14A · Apr 25, 2024
- vTv Therapeutics to be Acquired by G42 Healthcare Investments — 8-K · Mar 26, 2024
- MacAndrews & Forbes Amends vTv Therapeutics Stake — SC 13D/A · Mar 22, 2024
- vTv Therapeutics Appoints New CEO & Chairman — 8-K · Mar 14, 2024
- vTv Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 13, 2024
- Baker Bros. Advisors Files 13D for vTv Therapeutics — SC 13D · Mar 5, 2024
- vTv Therapeutics Files 8-K — 8-K · Mar 5, 2024
- vTv Therapeutics Strikes Deal with 03 Life Sciences, Leadership Changes — 8-K · Feb 28, 2024